Related Experiment Video
Updated: Jul 30, 2026

Analysis of Immune Cells in Single Sciatic Nerves and Dorsal Root Ganglion from a Single Mouse Using Flow Cytometry
Published on: December 6, 2017
Serglycin expression in CD2+ and CD14+ cells from patients with various rheumatic diseases
L A Omtvedt1, S O Kolset, J Thoen
1Centre for Rheumatic Diseases, The National Hospital, University of Oslo, Norway.
Abstract:
The objective of the study was to look at the in vivo expression of serglycin in cells taken from patients with an inflammatory disease. The mRNA expression of the small proteoglycan serglycin was investigated in macrophages/monocytes and T-cells derived from the synovial fluid and blood of six patients with various rheumatic diseases and from the blood of two control subjects. Our results demonstrate higher Levels of expression in CD14+ cetts taken from patients with chronic inflammatory diseases than in control subjects. This suggests that serglycin may play a role during the inflammatory process.

